A clinical trial to study the effects of Ayurvedic formulation containing Ashwagandha and Guduchi in improving the quality of life in patients of breast cancer receiving chemotherapy as treatment

INTERVENTION: Intervention1: Tablet PHP‐Cancer containing hydro‐alcoholic extracts of Withania somnifera 150mg and Tinospora cordifolia 200 mg: 500 mg BD for 6 months Control Intervention1: Tablet Placebo: 500 mg BD for 6 months CONDITION: Breast cancer receiving chemotherapy PRIMARY OUTCOME: The primary outcome measures will be 20% improvement in the QOL score over and above that obtained in the group receiving placebo and less than 10% difference in adverse events (including laboratory variables) between placebo and active treatment groups.‐‐‐‐‐‐Timepoint: SECONDARY OUTCOME: Not Applicable‐‐‐‐‐‐Timepoint: INCLUSION CRITERIA: 1. Female patients in age group of 18 to 60 years (irrespective of menopausal status) with a life expectancy of at least 6 months 2. Patients with breast cancer scheduled to receive chemotherapy 3. Patients ready to consent and to abide by trial related procedures